Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Divi's Laboratories, a leading global manufacturer of Active Pharmaceutical Ingredients (APIs) and advanced intermediates, provides innovative solutions for the pharmaceutical industry. With a strong focus on research, development, and production of high-quality pharmaceutical components, Divi's Laboratories supports the creation of life-saving medicines worldwide.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Divi's Laboratories is scheduled to report its next quarterly earnings on 11/09/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Divi's Laboratories last reported quarterly earnings on 7/31/2026 (Q2 2026). Earnings per share (EPS) came in at 33.95 INR.
Across its last 5 earnings reports, Divi's Laboratories stock moved by ±4% on average the following day. The largest reaction was +6.6% on 07/31/2026; 3 of 5 reactions were positive.
Divi's Laboratories has beaten analyst EPS estimates in 3 of its last 4 evaluated quarters (beat rate: 75%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 5 report dates (close to close).
Basis: 4 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.